Transcription of MULTISOURCE (GENERIC) PHARMACEUTICAL …
{{id}} {{{paragraph}}}
Working document July 2014 Document for comment 1 2 MULTISOURCE ( generic ) PHARMACEUTICAL 3 PRODUCTS: GUIDELINES ON REGISTRATION 4 REQUIREMENTS TO ESTABLISH 5 INTERCHANGEABILITY. REVISION 6 (JULY 2014) 7 8 REVISED DRAFT FOR COMMENT 9 10 11 World Health Organization 2014 12 All rights reserved. 13 This draft is intended for a restricted audience only, the individuals and organizations having received this draft. 14 The draft may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or 15 in whole, in any form or by any means outside these individuals and organizations (including the organizations' 16 concerned staff and member organizations) without the permission of the World Health Organization. The draft should 17 not be displayed on any website. 18 Please send any request for permission to: 19 Dr Sabine Kopp, Group Lead, Medicines Quality Assurance, Technologies, Standards and Norms, Department of 20 Essential Medicines and Health Products, World Health Organization, CH-1211 Geneva 27, Switzerland.
working document qas/14.583/rev.1 page 2 36 schedule for the proposed adoption process of document qas/14.583: 37 multisource (generic) pharmaceutical …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Guideline on quality of oral modified release, Guideline on quality of oral modified release products, Release, Guideline, Quality, Modified, ELEMENTAL IMPURITIES, Ich harmonised tripartite guideline, INVESTIGATION OF BIOAVAILABILITY AND, PHENOXYMETHYLPENICILLIN, Oral, GUIDELINES FOR BIOAVAILABILITY